Inova Fairfax Medical campus
Falls Church, Virginia, 22042, United States
Location status: Recruiting
NCT Number: NCT06273683
One in three women of reproductive age utilize tubal sterilization for contraception, and sterilization is often requested at time of cesarean delivery. Complete salpingectomy for the purpose of permanent sterilization at the time of cesarean birth is increasingly being performed worldwide.
A preferred complete salpingectomy technique for the purpose of sterilization at the time of cesarean delivery has not emerged in current practice. The objective is to compare short-term clinical outcomes and cost of salpingectomy using a hand-held bipolar energy instrument with those of traditional suture ligation. This retrospective cohort study will be conducted from 2017-2023 at a single tertiary care hospital. The investigators hypothesize that bipolar energy instrument use will not significantly improve clinical outcomes.
Interested in participating?
Request Info21 year and older
Female
Observational
Falls Church, Virginia, 22042, United States
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A bipolar energy instrument is used for complete salpingectomy at the time of cesarean delivery.
Traditional suture ligation technique is used for complete salpingectomy at the time of cesarean delivery.
Time frame: preoperatively and one day after surgery
Change in hemoglobin levels reported in gram per deciliter on postoperative day one, calculated as the difference between immediate preoperative and postoperative day 1 hemoglobin levels
Time frame: preoperatively and one day after surgery
Proportion of sterilization procedure completed by postoperative day one
Time frame: intraoperatively
estimated blood loss calculated and documented in milliliters at the end of the procedure
Time frame: intraoperatively
Rate of injury to abdominal/pelvic organs sustained during the procedure
Time frame: from day of surgery up to 30 days pospartum
any need for blood products transfusion intraoperatively through discharge
Time frame: intraoperatively
time necessary to complete the surgery from skin incision to end of skin closure
Time frame: from day of surgery up to 7 days postpartum
any admission to the intensive care unit for procedure-related complications
Time frame: from day of surgery up to 6 weeks postpartum
Duration of hospitalization in days from admission to discharge
Time frame: Day of initial dischage through 6 weeks postpartum
Any admission after initial discharge from the hospital
Time frame: postoperative day 0 through 6 weeks postpartum
Number of participants who return to the operating room due to initial procedure-related complications
Time frame: from day of surgery up to 7 days postparum
pain severity measured on a scale of 0 through 10
Time frame: postoperative day 0 through 6 weeks postpartum
any infection that occurs post-surgery in the abdomen, pelvis, abdominal walls or skin
Time frame: intraoperatively
cost difference between bipolar instrument and suture
Interested in participating?
Request InfoInova Health Care Services
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07758114
Chronic Respiratory Disease, Environmental Exposure
Galveston, Texas, United States
View Trial DetailsNCT06598098
Pregnancy Related
Greenville, North Carolina, United States
View Trial DetailsNCT06471790
Epidural; Anesthesia, Headache, Female Urogenital Diseases and Pregnancy Complications
Lyon, France
View Trial DetailsNCT06226155
Anxiety Disorders, Behavior
Harare, Zimbabwe
View Trial Details